Post-thrombotic syndrome (I87.0xx): Code Clinic guidance specifies that I87.0xx codes are only appropriate when the provider explicitly documents post-thrombotic syndrome or its equivalent
More Employers Will Explore Conditional Coverage Expect more employers to tie GLP-1 access to structured weight management programs that include coaching, nutrition, and fitness requirements
The dose escalation schedule most commonly follows a four-week progression: 0.25mg for weeks one through four, then 0.5mg for weeks five through eight, continuing upward until reaching your therapeutic maintenance dose
If every patient who applies gets approved, regardless of medical history, BMI, or contraindications, the clinical oversight is performative
In December 2025, Eli Lilly submitted the drug to the FDA for weight loss and plans to submit it for type 2 diabetes in 2026